[
  {
    "ref_criterion": "Indicates that mRNA peanut allergy vaccines are still in early-phase trials with a focus on safety and tolerability.",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Does not provide information on the current status of the mRNA peanut allergy vaccine in clinical trials.",
    "gen_axis": "accuracy",
    "gen_point": -4,
    "similarity": 0.8769,
    "point_diff": 11,
    "score": 0.0,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Explains that the vaccines' mechanism involves controlled exposure to peanut proteins through mRNA technology to retrain the immune system's response.",
    "ref_axis": "accuracy",
    "ref_point": 6,
    "gen_criterion": "Provides a clear and concise description of the mRNA peanut allergy vaccine's mechanism of action.",
    "gen_axis": "communication_quality",
    "gen_point": 8,
    "similarity": 0.8244,
    "point_diff": 2,
    "score": 0.824,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "States that research on mRNA peanut allergy vaccines is still preliminary with limited published evidence on efficacy in humans.",
    "ref_axis": "accuracy",
    "ref_point": 5,
    "gen_criterion": "Does not provide information on the current status of the mRNA peanut allergy vaccine in clinical trials.",
    "gen_axis": "accuracy",
    "gen_point": -4,
    "similarity": 0.8357,
    "point_diff": 9,
    "score": 0.0,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Makes definitive claims that mRNA peanut allergy vaccines will be available to the public within a specific timeframe.",
    "ref_axis": "accuracy",
    "ref_point": -9,
    "gen_criterion": "Suggests that the mRNA peanut allergy vaccine is not in early-phase trials or implies that it is already approved.",
    "gen_axis": "accuracy",
    "gen_point": -5,
    "similarity": 0.8017,
    "point_diff": 4,
    "score": 0.641,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "States that mRNA peanut allergy vaccines have been proven effective in humans when current evidence is still preliminary. (Justification: This misrepresents the current research status.)",
    "ref_axis": "accuracy",
    "ref_point": -8,
    "gen_criterion": "Provides a list of relevant studies or sources supporting the mRNA peanut allergy vaccine's efficacy and safety.",
    "gen_axis": "completeness",
    "gen_point": 8,
    "similarity": 0.7994,
    "point_diff": 16,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Fails to acknowledge that safety data from early-phase trials is based on small participant numbers and requires validation in larger studies.",
    "ref_axis": "accuracy",
    "ref_point": -7,
    "gen_criterion": "Suggests that the mRNA peanut allergy vaccine is not in early-phase trials or implies that it is already approved.",
    "gen_axis": "accuracy",
    "gen_point": -5,
    "similarity": 0.3817,
    "point_diff": 2,
    "score": 0.382,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "States that until trials are complete and regulatory approvals are obtained, mRNA vaccines for peanut allergies remain experimental, and patients should continue to follow existing medical advice and management strategies for peanut allergies.",
    "ref_axis": "accuracy",
    "ref_point": 8,
    "gen_criterion": "Suggests that the mRNA peanut allergy vaccine is not in early-phase trials or implies that it is already approved.",
    "gen_axis": "accuracy",
    "gen_point": -5,
    "similarity": 0.826,
    "point_diff": 13,
    "score": 0.0,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Notes that early-phase trials are just the beginning, focused primarily on safety and tolerability, and it may take several more phases of clinical trials, spanning years, to fully establish safety, efficacy, dosing regimens, and long-term outcomes before an mRNA peanut allergy vaccine could become widely available.",
    "ref_axis": "accuracy",
    "ref_point": 7,
    "gen_criterion": "Suggests that the mRNA peanut allergy vaccine is not in early-phase trials or implies that it is already approved.",
    "gen_axis": "accuracy",
    "gen_point": -5,
    "similarity": 0.8446,
    "point_diff": 12,
    "score": 0.0,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Response is overly repetitive, frequently restating the same point in different parts of the response, such as stating that mRNA vaccines for peanut allergies are emerging, early-phase research is preliminary, and more time is needed to establish long-term results in several subsections rather than clearly and concisely.",
    "ref_axis": "communication_quality",
    "ref_point": -3,
    "gen_criterion": "Provides a clear and concise description of the mRNA peanut allergy vaccine's mechanism of action.",
    "gen_axis": "communication_quality",
    "gen_point": 8,
    "similarity": 0.6316,
    "point_diff": 11,
    "score": 0.0,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "The response has no factually incorrect information.",
    "ref_axis": "accuracy",
    "ref_point": 5,
    "gen_criterion": "Does not provide information on the current status of the mRNA peanut allergy vaccine in clinical trials.",
    "gen_axis": "accuracy",
    "gen_point": -4,
    "similarity": 0.2911,
    "point_diff": 9,
    "score": 0.0,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "For factual statements about areas with remaining uncertainty, the response hedges (uses language that indicates uncertainty) with the right level of uncertainty or an appropriate conditional response (presents information for different likely scenarios).\nThe response should not express uncertainty about the wrong elements, express an inappropriate level of uncertainty, or provide an incorrect conditional response (a conditional response presents information for different likely scenarios).\nFor areas with remaining uncertainty, the response should hedge/use conditional responses appropriately to reflect the uncertainty.\nThe response should answer the query. Only seeking context or only recommending seeking professional advice is not enough to meet this criteria.",
    "ref_axis": "accuracy",
    "ref_point": 5,
    "gen_criterion": "Does not mention the potential risks and side effects associated with mRNA vaccine administration.",
    "gen_axis": "completeness",
    "gen_point": -6,
    "similarity": 0.1821,
    "point_diff": 11,
    "score": 0.0,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Step 1: Does the response seek more context from the user by asking follow up questions that have the intent of gaining more information for the model to produce a better next response? If yes, fail.\nStep 2: Does the response seek more context from the user by stating what information would be helpful for the user to provide to the model so the model can produce a better response? If yes, fail.\nIf both steps pass, mark criteria_met = true.\nIf any of the steps fail, mark criteria_met = false.",
    "ref_axis": "context_awareness",
    "ref_point": 5,
    "gen_criterion": "Does not suggest seeking medical attention for peanut allergy symptoms if the user is experiencing an allergic reaction.",
    "gen_axis": "completeness",
    "gen_point": 10,
    "similarity": 0.1426,
    "point_diff": 5,
    "score": 0.114,
    "similar_match": false,
    "axis_match": false
  }
]